Sanofi and Regeneron receive CHMP positive opinion for Kevzara® (sarilumab) to treat adult patients with moderately to severely active rheumatoid arthritis

25th April 2017 Uncategorised 0

Sanofi

More: Sanofi and Regeneron receive CHMP positive opinion for Kevzara® (sarilumab) to treat adult patients with moderately to severely active rheumatoid arthritis
Source: MDlinx